Next Generation Glaucoma Treatment
Understanding Glaucoma
Glaucoma is a disease of high pressure inside the eye that is caused by fluid build-up. Eye fluid helps keep the eye healthy, but when the fluid cannot exit or drain, eye pressure goes up. High intraocular pressure (IOP) damages the nerve at the back of the eye, resulting in vision loss over time.
Currently, the only way to limit the effects of glaucoma progression on vision is to lower the pressure inside the eye. Usually, a combination of prescription eye drops, implants, or surgery that removes tissue is used to achieve this.
A New Approach with ELIOS™
The ELIOS procedure is an innovative glaucoma treatment that can be performed at the same time as cataract surgery. The procedure preserves the trabecular meshwork, is broadly adoptable by surgeons, and does not require an implant.
By using excimer laser light technology to create microscopic openings in the trabecular meshwork, ELIOS is designed to facilitate outflow of aqueous. ELIOS has been CE-marked in Europe and is currently undergoing investigational trials in the United States.
The Interventional Glaucoma Podcast
Join global thought leaders as they engage in unscripted discussions about the latest innovations in Interventional Glaucoma; an inspiring and thought-provoking mindset that prioritizes patient-centered care and challenges ophthalmologists to rethink their treatment strategies.
Our Mission: Addressing an Unmet Need
Cataract surgery is the most routinely performed surgery in the world with approximately 32 million procedures expected to be performed this year.1 Up to 20% of patients who need cataract surgery also have glaucoma or ocular hypertension.2 However, even though cataract surgery provides an optimal window for glaucoma treatment, it has not become a routine consideration for cataract patients.
At ELIOS, we see an opportunity to address one of the most common causes of blindness in the world during the most commonly performed surgical procedure in the world. Our goal is to make combining cataract and glaucoma treatment the new standard of care.
Elios Vision Advisory Boards
Our commercial and medical advisory boards are composed of well-respected surgeons who are active in glaucoma care and management and in researching this disease to discover the best treatments.
Commercial Advisory Board
Sahar Bedrood, MD, PhD
Advanced Vision Care
John Berdahl, MD
Vance Thompson Vision
Eric Donnenfeld, MD
Ophthalmic Consultants of Long Island & Connecticut
Christine Funke, MD
Barnet Dulaney Perkins Eye Center
Cathleen McCabe, MD
The Eye Associates
Robert Weinstock, MD
Eye Institute of West Florida
William Wiley, MD
Cleveland Eye Clinic
Blake Williamson, MD
Williamson Eye Center
Gary Wortz, MD
Commonwealth Eye Surgery
Elizabeth Yeu, MD
Virginia Eye Consultants
Medical Advisory Board
Ike K. Ahmed, MD
University of Toronto
Moran Eye
Medical Monitor
Louis B. Cantor, MD
Indiana University
Ian Conner, MD, PhD
University of Pittsburgh
Nathan Radcliffe, MD
New York Eye Surgery Center
Thomas Samuelson, MD
Minnesota Eye Care Consultants
Manjool Shah, MD
NYU Langone Eye Center
Arsham Sheybani, MD
Washington University in St. Louis